PIK3CG
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
Also known as: PK3CG_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P48736
- Gene
- PIK3CG
- Ensembl
- ENSG00000105851
- Chromosome
- 7
- Canonical length
- 1102 aa
- Protein class
- Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Cytosol
OverviewNCBI Gene
Phosphoinositide 3-kinases (PI3Ks) phosphorylate inositol lipids and are involved in the immune response. The protein encoded by this gene is a class I catalytic subunit of PI3K. Like other class I catalytic subunits (p110-alpha p110-beta, and p110-delta), the encoded protein binds a p85 regulatory subunit to form PI3K. This gene is located in a commonly deleted segment of chromosome 7 previously identified in myeloid leukemias. Several transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jun 2015]
Canonical amino-acid sequenceUniProt
1102 residues, UniProt reviewed canonical sequence.
>P48736|PIK3CG
1 MELENYKQPV VLREDNCRRR RRMKPRSAAA SLSSMELIPI EFVLPTSQRK CKSPETALLH
61 VAGHGNVEQM KAQVWLRALE TSVAADFYHR LGPHHFLLLY QKKGQWYEIY DKYQVVQTLD
121 CLRYWKATHR SPGQIHLVQR HPPSEESQAF QRQLTALIGY DVTDVSNVHD DELEFTRRGL
181 VTPRMAEVAS RDPKLYAMHP WVTSKPLPEY LWKKIANNCI FIVIHRSTTS QTIKVSPDDT
241 PGAILQSFFT KMAKKKSLMD IPESQSEQDF VLRVCGRDEY LVGETPIKNF QWVRHCLKNG
301 EEIHVVLDTP PDPALDEVRK EEWPLVDDCT GVTGYHEQLT IHGKDHESVF TVSLWDCDRK
361 FRVKIRGIDI PVLPRNTDLT VFVEANIQHG QQVLCQRRTS PKPFTEEVLW NVWLEFSIKI
421 KDLPKGALLN LQIYCGKAPA LSSKASAESP SSESKGKVQL LYYVNLLLID HRFLLRRGEY
481 VLHMWQISGK GEDQGSFNAD KLTSATNPDK ENSMSISILL DNYCHPIALP KHQPTPDPEG
541 DRVRAEMPNQ LRKQLEAIIA TDPLNPLTAE DKELLWHFRY ESLKHPKAYP KLFSSVKWGQ
601 QEIVAKTYQL LARREVWDQS ALDVGLTMQL LDCNFSDENV RAIAVQKLES LEDDDVLHYL
661 LQLVQAVKFE PYHDSALARF LLKRGLRNKR IGHFLFWFLR SEIAQSRHYQ QRFAVILEAY
721 LRGCGTAMLH DFTQQVQVIE MLQKVTLDIK SLSAEKYDVS SQVISQLKQK LENLQNSQLP
781 ESFRVPYDPG LKAGALAIEK CKVMASKKKP LWLEFKCADP TALSNETIGI IFKHGDDLRQ
841 DMLILQILRI MESIWETESL DLCLLPYGCI STGDKIGMIE IVKDATTIAK IQQSTVGNTG
901 AFKDEVLNHW LKEKSPTEEK FQAAVERFVY SCAGYCVATF VLGIGDRHND NIMITETGNL
961 FHIDFGHILG NYKSFLGINK ERVPFVLTPD FLFVMGTSGK KTSPHFQKFQ DICVKAYLAL
1021 RHHTNLLIIL FSMMLMTGMP QLTSKEDIEY IRDALTVGKN EEDAKKYFLD QIEVCRDKGW
1081 TVQFNWFLHL VLGIKQGEKH SALocalizationUniProt · AlphaFold · HPA
Whether an antibody against PIK3CG can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 41 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 41 nTPM
- tonsil: 18 nTPM
- lymph node: 18 nTPM
- thymus: 15 nTPM
- appendix: 11 nTPM
- spleen: 10 nTPM
Single-cell type
- tuft cells: 565 nCPM
- neutrophil progenitors: 331 nCPM
- neutrophils: 327 nCPM
- plasma cells: 147 nCPM
- pdcs: 112 nCPM
- monocyte progenitors: 83 nCPM
Immune cell
- non-classical monocyte: 44 nTPM
- eosinophil: 24 nTPM
- neutrophil: 23 nTPM
- intermediate monocyte: 18 nTPM
- basophil: 11 nTPM
- naive B-cell: 10 nTPM
Brain region
- white matter: 10 nTPM
- medulla oblongata: 7.3 nTPM
- thalamus: 6 nTPM
- spinal cord: 5.6 nTPM
- pons: 5.2 nTPM
- cerebral cortex: 4.5 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PIK3CG.
Disease | AllUniProt
Conditions PIK3CG is implicated in, by any mechanism.
- Immunodeficiency 97 with autoinflammation (IMD97) MIM:619802
Disease | GeneticClinVar
4 pathogenic / likely-pathogenic of 159 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Immunodeficiency 97 with autoinflammation
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.6
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.97
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adaptive immune response
- angiogenesis
- cell migration
- cellular response to cAMP
- dendritic cell chemotaxis
- endocytosis
- G protein-coupled receptor signaling pathway
- hepatocyte apoptotic process
- immune response
- inflammatory response
- innate immune response
- mast cell degranulation
- natural killer cell chemotaxis
- negative regulation of cardiac muscle contraction
- negative regulation of fibroblast apoptotic process
- negative regulation of triglyceride catabolic process
- neutrophil chemotaxis
- neutrophil extravasation
- phosphatidylinositol 3-kinase/protein kinase B signal transduction
- phosphatidylinositol phosphate biosynthetic process
- phosphatidylinositol-3-phosphate biosynthetic process
- phosphatidylinositol-mediated signaling
- phospholipase C-activating G protein-coupled receptor signaling pathway
- platelet aggregation
- positive regulation of acute inflammatory response
- positive regulation of cytokine production
- positive regulation of cytosolic calcium ion concentration
- positive regulation of endothelial cell migration
- positive regulation of MAP kinase activity
- positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- positive regulation of Rac protein signal transduction
- regulation of angiogenesis
- regulation of calcium ion transmembrane transport
- regulation of cell adhesion mediated by integrin
- respiratory burst involved in defense response
- secretory granule localization
- sphingosine-1-phosphate receptor signaling pathway
- T cell activation
- T cell chemotaxis
- T cell proliferation
Molecular functions
- 1-phosphatidylinositol-3-kinase activity
- 1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity
- 1-phosphatidylinositol-4-phosphate 3-kinase activity
- ATP binding
- ephrin receptor binding
- identical protein binding
- protein kinase activity
- protein serine kinase activity
- protein serine/threonine kinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Phosphatidylinositol 3-kinase Ras-binding (PI3K RBD) domain
- Phosphatidylinositol 3-/4-kinase, catalytic domain
- Phosphoinositide 3-kinase, accessory (PIK) domain
- C2 phosphatidylinositol 3-kinase-type domain
- Phosphatidylinositol 3-kinase, adaptor-binding domain
- Protein kinase-like domain superfamily
- Phosphatidylinositol 3-/4-kinase
- Armadillo-type fold
- Phosphatidylinositol 3-/4-kinase, conserved site
- Ubiquitin-like domain superfamily
- C2 domain superfamily
- Phosphatidylinositol 3-/4-kinase, catalytic domain superfamily
- Phosphoinositide 3-kinase, accessory (PIK) domain superfamily
- Phosphatidylinositol 3- and 4-kinase
- Phosphoinositide 3-kinase family, accessory domain (PIK domain)
- Phosphoinositide 3-kinase C2
- PI3-kinase family, ras-binding domain
- PIK3 catalytic subunit gamma, adaptor-binding domain
- PIK3 catalytic subunit gamma adaptor-binding domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PIK3CG in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PIK3CG as an antibody target. Whether an autoantibody or antibody against PIK3CG could matter depends on whether native PIK3CG is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PIK3CG is annotated at the cell surface, where native PIK3CG is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PIK3CG as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...